Post on 24-May-2020
Efforts'made'by'the'University'of'Costa'Rica'to'promote'Pharmacovigilance'
!'Victoria'Hall'Ramírez,'Pharm'D,'MS'in'Economics.'
Professor,!Pharmaceu.cal!Care!and!Clinical!Pharmacy!Department,!School!of!Pharmacy!Na.onal!Drug!Informa.on!Center,!Pharmaceu.cal!Research!ins.tute!
University!of!Costa!Rica!
Faculty'and'researchers'involved' '
• CIMED`s team • Pharmaceutical Care I and II
courses professors • Pharmacoepidemiology Topics
course professors • Students involved with projects
2
• The author declare no conflict of interest (financial and non-financial).
3
Conflict'of'interest '
• Introduction • Objective • Results
- The Pharmacovigilance System in Costa Rica - School of Pharmacy - Experiences of teaching, social work and research - Colaboration with other stakeholders
• Challenges
4
PresentaGon'overview '
• The School of Pharmacy of the University of Costa Rica, has been compromise since 1897 with the Costa Rica`s population health.
5
Training!of!pharmaceu.cal!professionals! Provision!of!services!
Development!of!ac.vi.es!that!
directly!affect!the!public!health!of!the!
country!
IntroducGon '
• Describe the efforts made the School of Pharmacy of the University of Costa Rica and the challenges the academia have in promoting Pharmacovigilance
6
ObjecGve '
7
Ministry!of!Health!
Na.onal!Health!Security!System!
(CCSS)!
Na.onal!Insurance!Ins.tute!(INS)! Private!sector!
Ins.tute!of!Aqueducts!and!Sewers!(AyA)!
Universi.es!
Other!ins.tu.ons:!IAFA,!INCIENSA!
Source:!Presentación!Atención!Primaria!en!Salud!y!Sistemas!Universales!Dr.!Álvaro!Salas,!2014.!
The'NaGonal'Health'System'in'Costa'Rica '
8
• Popula'on:*5*003*402*inhabitants • 7.6% older than 65 years
• 3 levels - Hospitals - Clinics - Basic primary care facilities
• Private sector Source:!Presentación!Atención!Primaria!en!Salud!y!Sistemas!Universales!Dr.!Álvaro!Salas,!2014!and!INEC.!
The'NaGonal'Health'System'in'Costa'Rica '
• Ministry of Health • National Pharmacovigilance Centre • National Pharmacovigilance Committe • Good Pharmacovigilance Practices* • All the health care proffessional should report adverse
drug reactions (ADR) - Printed Form - Online platform – Noti Facedra
9
The'Pharmacovigilance'System'in'Costa'Rica '
10
• Creation of new courses. • Incorporation of diverse
didactic techniques, besides lectures and laboratory sessions,
such as role plays, community work, case analysis and
simulations.
• Definition of conceptual, procedimental and attitudinal
contents in each area. • 17 elective courses - 6.07% of the
total credits of the curriculum
• A new curriculum was developed through a process of reflection, research and selection of contents from interviews with employers, students and teachers, along with the analysis of dominant, decadent and emerging practices in many areas, and according to international realities
Source:!!Arias!Mora!F!et!al.!Case!report:!designing!a!new!curriculum!for!a!PharmD!Degree!Faculty!of!Pharmacy,!University!of!Costa!Rica,!2016.!FIP!Congress.!Seoul,!Korea.!2017!!
School'of'Pharmacy'–'New'curriculum '
11
Pharmacovigilance'in'different'courses''
Pharmaceu.cal!Care!and!!Clinical!Pharmacy!
Department!
• 5!courses!• III,!IV!and!V!year!
Industrial!Pharmacy!Department!
• 5!courses!• III,!IV!y!V!year!
Pharmacology,!Toxicology!and!
Pharmacodependence!Department!• 4!courses!
• I,!!IV!and!V!year!
• Mandatory courses in IV and V year • 50-60 students • 8 pharmacist • 2 Pharmacovigilance Lectures about
- Definitions and history - Drug Adverse Reactions and notification in Costa Rica - Medication Errors - Counterfeit medicines
12
PharmaceuGcal'Care'I'and'II '
• Practice
• Visit to National Pharmacovigilance Center - Causality assesment workshop
• Practice in community pharmacy • Identification and report of ADR of a patient in therapeutic
follow-up* - Pharmaceutical interventions to manage the ADR
13
PharmaceuGcal'Care'I'and'II '
Pharmacoepidemiology'Topics '
• Elective course in V year • 10-15 students • 3 pharmacist • Pharmacovigilance
- International Pharmacovigilance Programe - Lectures with proffesionals of industry, regulatory affairs,
hospitals and the National Pharmacovigilance Center. - Interviews with professionals about pharmacoepidemiology
(pharmacovigilance and pharmacoeconomy)
14
Pharmacoepidemiology'Topics '
17
Source:!!Hall!V,!Jiménez!LG,!Rocha!M.!Opinion!of!Costa!Rican!pharmacists!regarding!some!aspects!of!the!Spontaneous!Adverse!Drug!Reac.ons!repor.ng,!2017.!ISoP!Liverpool,!2017.!!!
Pharmacoepidemiology'Topics '
18
In!rela.on!to!PV'regulaGons'in!Costa!Rica,!63.16%'of!the!pharmacist!know!about!the!
existence!of!the!one!that!creates!the!Na.onal!Pharmacovigilance!System!
(NPVS)!!and!the!Na.onal!Pharmacovigilance!Center!(NPVC)!and!
52.63%'about!the!one!that!regulated!the!Good!Pharmacovigilance!Prac.ces.!
Source:!!Hall!V,!Jiménez!LG,!Rocha!M.!Opinion!of!Costa!Rican!pharmacists!regarding!some!aspects!of!the!Spontaneous!Adverse!Drug!Reac.ons!repor.ng,!2017.!ISoP!Liverpool,!2017.!!!
Pharmacoepidemiology'Topics '
19
Source:!!Hall!V,!Jiménez!LG,!Rocha!M.!Opinion!of!Costa!Rican!pharmacists!regarding!some!aspects!of!the!Spontaneous!Adverse!Drug!Reac.ons!repor.ng,!2017.!ISoP!Liverpool,!2017.!!!
Final'research'projects '• Thesis • Interships • Graduation project • Different scenarios:
- Hospitals - Industry - Academia - Specialized centers
20
An'experience'with'an'industry '
21
Health Authorities
Academia
Industry
Source:!!Calderón!Díaz!T!et!al.!Fomento!de!la!farmacovigilancia,!como!un!servicio!profesional!farmacéu.co:!La!experiencia!del!trabajo!conjunto!entre!academia!e!industria!farmacéu.ca.!SIMPODADER!Internacional,!Granada,!Spain.!2016.!!
An'experience'with'an'industry '
22
• Bibliographic review • Key words: pharmacovigilance, adverse drug reaction, signal
detection, risk plan management • EBSCO, Access Pharmacy, Pubmed • Legislation in Central America and the Caribbean
Source:!!Calderón!Díaz!T!et!al.!Fomento!de!la!farmacovigilancia,!como!un!servicio!profesional!farmacéu.co:!La!experiencia!del!trabajo!conjunto!entre!academia!e!industria!farmacéu.ca.!SIMPODADER!Internacional,!Granada,!Spain.!2016.!!
An'experience'with'an'industry '
23
Source:!!Calderón!Díaz!T.!Elementos!Básicos!de!Farmacovigilancia.!1!edición.!2016!!
An'experience'with'an'industry '
24
Source:!!Calderón!Díaz!T!et!al.!Fomento!de!la!farmacovigilancia,!como!un!servicio!profesional!farmacéu.co:!La!experiencia!del!trabajo!conjunto!entre!academia!e!industria!farmacéu.ca.!SIMPODADER!Internacional,!Granada,!Spain.!2016.!!
• Definitions and history • Adverse Drug Reactions and the importance of the report • Periodic Safety Reports • Signal Detection • Risk Plan Management • Good Pharmacovigilance Practices • Legislation in the Region
An'experience'with'an'industry '
25
Source:!!Calderón!Díaz!T.!Elementos!Básicos!de!Farmacovigilancia.!1!edición.!2016!!
An'experience'with'an'industry'V'Learning'experience'
26
• Innovative work experience between different stakeholders • Publication for the Region • Promotes report based in the knowledge • Promotes the development and strengthening of legislation in
the region
Source:!!Calderón!Díaz!T!et!al.!Fomento!de!la!farmacovigilancia,!como!un!servicio!profesional!farmacéu.co:!La!experiencia!del!trabajo!conjunto!entre!academia!e!industria!farmacéu.ca.!SIMPODADER!Internacional,!Granada,!Spain.!2016.!!
An'experience'with'an'private'hospital '
27
Source:!!Aguilar!Marín!Luis!Diego.!Diseño!de!un!servicio!de!SFT!basado!en!el!método!Dáder!para!su!aplicación!en!el!programa!de!AF!en!un!hospital!privado!en!Costa!Rica.!TFG.!2017!
An'experience'with'an'private'hospital '
28
• Development of Standart Operating Procedure - Each phase of therapeutic-follow up with Dader Method - Report of and Adverse Drug Reaction: printed form and on line platform
• Training to pharmacist • Quality of services indicators
-Including number of ADR reports
Source:!!Aguilar!Marín!Luis!Diego.!Diseño!de!un!servicio!de!SFT!basado!en!el!método!Dáder!para!su!aplicación!en!el!programa!de!AF!en!un!hospital!privado!en!Costa!Rica.!TFG.!2017!
Job'posiGons'in'PV'of'our'graduates '
29
Source:!!School!of!Pharmacy,!UCR.!Facebook!Profile!12th!November!2018!
2015: 5%
2016: 17%
'Pharmacovigilance'and'social'acGon'in'the'School'of'Pharmacy'
30
• Medicine rational use in older adults and other vulnerable populations
• Actions with school and high school students
• Prevention of poisoning
Source:!Faculty!of!Pharmacy!web!page:!hhp://farmacia.ucr.ac.cr/node/81!!
32
Source:!!Jeimy!Blanco.!Pharm!D.!Director!of!LAYAFA.!www.inifar.ucr.ac.cr!!
• Official Laboratory for Quality control of Medicines in Costa Rica
-Guarantee the quality and safety of the medicines registered and sold in the community pharmacies
• Participation in the interinstitucional Commission against counterfeit and ilegal health products – Ministry of Health
PharmaceuGcal'Analysis'and'Advisor'Laboratory'(LAYAFA)'
33
PharmaceuGcal'Analysis'and'Advisor'Laboratory'(LAYAFA)'
Source:!Jeimy!Blanco.!Pharm!D.!Director!of!LAYAFA.!No.cias!Repretel.!December,!2017.!
NaGonal'Drug'InformaGon'Center'(CIMED) '
34
Medica.on!Therapy!
Management!
Public!Health!
Drug!Informa.on!
NaGonal'Drug'InformaGon'Center'(CIMED)!!'• 11 pharmacist and 15 research assistants
• Inquiries about ADR and toxicity: - 28.40% during 2012-2016
• ADR reports to National Pharmacovigilance Center: - 69 reports in 2017
• Online courses about pharmacovigilance - 2: PV basics and medication errors
• Workshops with pharmacist -2: internal and external
35
Source:!CIMED!Annual!Reports.!
TherapeuGc'follow'up'to'paGents'with'chronic'diseases '
36
• CIMED and Pharmaceutical Care II course • Combination of
- Social action - Research - Teaching
• Process - Interview - Identification of drug related problems - Pharmaceutical interventions
Adverse'Drug'ReacGons'idenGfied'2012V2017'n=299'paGents '
37
59!ADR!iden.fied!in!the!1st!interview:!!
48!!female,!!11!!male!
56!!of!the!ADR!were!described!in!the!
literature!
No!ADR!requiered!hospitaliza.on!
Source:!Project!Final!Report,!2017.!!
38
AVAlimentary'tract'and'metabolism'
20%'
BVBlood'and'blood'forming'organs'3%'
CVCardiovascular''System'26%'
DVDermatologicals'2%'
HVSystemic'hormonal'exc'sex'hormones'and'insulins'
8%' LVAnGneoplasGc'and'inmunomodulators'
5%'
MVMuscoloVskeletal'system''15%'
NVNervous'system'13%'
RVRespiratory'system'6%'
VVVarious''2%'
GRAPHIC'NO.'1'ATC'CLASSIFICATION'OF'SUSPICIOUS'DRUGS'INVOLVED'WITH'ADR'IN'PATIENTS'IN'THERAPEUTICO'FOLLOWVUP'SFT'2012V2017'
N=61'
Source:!Project!Final!Report,!2017.!!
Challenges'for'the'Academy '
39
Strengthening partnerships with institutions specialized in patient safety
Publication of experiences that contribute to the generation of knowledge with country data
Measurement of the impact of the actions developed that allow decision-making
Challenges'for'the'Academy '
40
Strengthening of the practice in the curriculum
Joint work between Schools that allows to strengthen the teaching of the PV
Take'home'messages'
• Everyone is involved in Pharmacovigilance, no matter the area of pharmacy.
• It`s necessary to promote the interdisciplinary training at universities with activities at real settings.
• Pharmacovigilance must be an combined effort of different stakeholders.
• Each stakeholder has their own strength so they have to work together to maximize the benefits.
41
Contacts'
• CIMED cimed.inifar@ucr.ac.cr
• LAYAFA layafa.inifar@ucr.ac.cr
• INIFAR inifar@ucr.ac.cr
• School of Pharmacy decanatura.farmacia@ucr.ac.cr
42
Efforts'made'by'the'University'of'Costa'Rica'to'promote'Pharmacovigilance'
!'Victoria'Hall'Ramírez,'Pharm'D,'MS'in'Economics.'
Professor,!Pharmaceu.cal!Care!and!Clinical!Pharmacy!Department,!School!of!Pharmacy!Na.onal!Drug!Informa.on!Center,!Pharmaceu.cal!Research!ins.tute!
University!of!Costa!Rica!